View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Together Again, Where Innovation Takes Place: Meet with Softigel® by Procaps During CPhI North America 2021

At Softigel by Procaps, we develop complex products encapsulated in softgel dosage forms and other delivery systems, high potency APIs, differentiated OTC products and nutritional supplements in novel technologies that can help customers get their products to market faster and in an innovative way.

At CPhI North America, Softigel seeks new OTC consumer healthcare, generic Rx and pharma customers with collaboration opportunities in the US, other highly regulated markets or elsewhere worldwide. From simple to complex formulations, clinical to commercial manufacturing, and concept to market, we offer the technical expertise you need and the innovation you demand. Our team of experts will be delighted to sit with you, discuss mutual opportunities and live the Softigel experience.

Companies seek our softgel expertise and cGMP manufacturing facilities approved by some of the most demanding regulatory agencies in the world (including FDA, MHRA, TGA, and many others) to help them bring generic softgel products to market, or, they are brand marketers seeking alternate softgel contract manufacturing capacity with special interest in our novel and proprietary technology platforms which offer their brands distinct consumer advantages and life cycle renewal opportunities.

We´d love to meet with big pharma and generic companies of the region, also emerging companies and nutraceutical businesses interested in generics, specialized nutraceuticals and brand customization, to expand their portfolios in innovative dosage forms.

To schedule a meeting with Softigel by Procaps, click here. August 10-12, Stand #1101

In recent years, the development of highly potent molecules has become more frequent, and around 25% of the components that are being developed are classified...
Cannabis-based products are manufactured, mainly, from oils obtained from a synthetic way as Dronabinol or obtained from plants of genus Cannabis, as Cannabidiol (CBD) oils.
The present is an overview of the state-of-the-art for vegetarian soft capsules in terms of materials (sourcing and demand), applications, processing, products and a general...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology